뉴스

• Daehwa, Dongkook Defy Market Slump…G2GBIO Falls More Than 10%[K-Bio Pulse] Pharmaceutical and biotech stocks diverged on company-specific developments as South Korean equities fell across both major markets. Daehwa Pharmaceutical gaine www.edaily.co.kr · 2026.10.13
• Inverse ETFs Dominate Bear Market [K-Bio Pulse] On July 29, South Korea’s domestic stock market experienced continued weakness, leading inverse Exchange Traded Funds (ETFs) tracking the Kosdaq’s d www.edaily.co.kr · 2026.07.30
• Market Fluctuates, Daehwa Pharm, LabGenomics, and NeoImmuneTech Rise[K-Bio Pulse] On the 7th, amid mixed trading in the South Korean stock market, pharmaceutical and biotech companies demonstrating clear earnings growth and solid momentum sto www.edaily.co.kr · 2026.08.10
• Biotech Stocks Rally with Market Rebound; Orum Therapeutics Jumps 18% [K-Bio Pulse] On July 31, South Korean pharmaceutical and biotech stocks broadly advanced as domestic equities rebounded, with bargain hunting returning to beaten-down growth www.edaily.co.kr · 2026.08.01
• Mixed Market, Solid Footing: Psomagen and Jetema Stand Out [K-Bio Pulse] While the domestic stock market has recently remained mixed and struggled to find a clear direction, the pharmaceutical and biotech sectors have carved out an u www.edaily.co.kr · 2026.07.02
• Genome & Company·LabGenomics Rally in Korea Stock Market[K-BIO PULSE] South Korean pharmaceutical, biotech and healthcare stocks staged a broad-based rally on June 9, as sector-specific catalysts drove sharp gains in select names www.edaily.co.kr · 2026.06.10